Video Experimental Relacionado
Updated: Apr 29, 2026
Isolation of Mouse Respiratory Epithelial Cells and Exposure to Experimental Cigarette Smoke at Air Liquid Interface
Published on: February 21, 2011
Mitsugumin 53 Protege Contra Lesiones Pulmonares por Inhalación de Humo Suprimiendo la Respuesta Proinflamatoria en
Daniel Z Aziz1, C Chase Binion2, Xiaoliang Wang1
1University of Virginia, Department of Surgery, Charlottesville, VA, USA.
Objective(S):
This study investigates the therapeutic potential of recombinant human Mitsugumin 53 (rhMG53) in a rodent model of smoke-induced acute lung injury (SI-ALI). We hypothesize that administration of rhMG53 will improve pulmonary function and attenuate inflammation following SI-ALI.
Methods:
Sprague Dawley rats (n=6-9/group, 300-400g) underwent smoke inhalation or sham. Smoke-exposed rats received intravenous rhMG53 or saline. Arterial blood gases were obtained at baseline and 2, 6, and 24 hours post smoke inhalation. Lung tissue collected at 24 hours was analyzed via histopathology, immunofluorescence, bulk RNA sequencing, quantitative PCR, and western blotting.
Results:
Six hours after smoke exposure, saline-treated rats exhibited dampened partial pressure of oxygen, whereas the rhMG53 group showed significant improvement (62.67±15.81 vs. 75.83±12.16 mmHg, P<.01). By 24 hours, saline-treated animals remained significantly hypoxemic (79.33 mmHg, P<.01 vs. baseline), while rhMG53-treated rats recovered to baseline (87.17 mmHg), trending toward significantly higher oxygenation versus saline (P=0.0503). Smoke-exposed saline-treated rats exhibited increased overall histopathological scores, which were reduced with rhMG53 (0.60±0.17 vs. 0.37±0.05, P<.01). Gene ontology analysis revealed rhMG53 mitigated smoke-induced upregulation of inflammatory response pathways. Induction of pro-inflammatory genes and elevation of NLRP3 inflammasome expression observed in smoke-exposed saline-treated lungs was significantly suppressed by rhMG53, as corroborated by qPCR and western blotting.
Conclusions:
This study provides preclinical evidence for rhMG53 as a potential therapeutic for SI-ALI. RhMG53 improved oxygenation, reduced neutrophilic inflammation, and suppressed NLRP3 inflammasome activation. Further investigations in diverse models of ALI are warranted to define the therapeutic scope and translational potential of rhMG53.
